← All organizations

The Peter Doherty Institute

Academic/HospitalWebsite ↗

Also known as: The Peter Doherty Institute for Infection and Immunity

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

Nov 30, 2025

Timeline

2010s

Jan 1, 2014
The Peter Doherty Institute— Founded

Drugs by trial phase (25 distinct, 16 trials)

Phase 4 (5 own, 0 via acquisition)

Phase 3 (12 own, 0 via acquisition)

Phase 2 (6 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

streptococcus pyogenes

Other trials (1 own, 0 via acquisition)

acellular pertussis vaccine (including diptheria and tetanus toxoids)

Indications

Studied for

Recent trials (16)

NCT07253688CollaboratorPhase 3Nov 30, 2025
NCT06637332CollaboratorPhase 4Nov 14, 2024
NCT05387317CollaboratorPhase 3Feb 28, 2023
NCT05543356CollaboratorPhase 3Feb 28, 2023
NCT05658523CollaboratorPhase 3Feb 28, 2023
NCT05668026CollaboratorPhase 1/Phase 2Feb 1, 2023
NCT05204550CollaboratorPhase 2/Phase 3Jan 1, 2023
NCT05265065CollaboratorPhase 3May 27, 2022
NCT05228730CollaboratorPhase 3May 2, 2022
NCT05137119CollaboratorPhase 4Dec 1, 2021
NCT04483960CollaboratorPhase 3Jul 28, 2020
NCT03837756CollaboratorPhase 2May 6, 2019
NCT03361163CollaboratorPhase 1Jun 27, 2018
NCT03198559Lead sponsorPhase 1/Phase 2Aug 8, 2017
NCT03063788CollaboratorPhase 1May 1, 2017

Details

Founded: Melbourne, AU Jan 1, 2014
Last known activity: Nov 30, 2025